1,071
Participants
Start Date
August 31, 2010
Primary Completion Date
November 30, 2012
Study Completion Date
November 30, 2012
Placebo
Placebo that represents comparator
tiotropium Respimat® low dose
IMP
Placebo
Placebo that represents comparator
Placebo
Placebo that represents comparator
tiotropium Respimat® high dose
IMP
50 mcg salmeterol HFA MDI
Active comparator
Placebo
Placebo that represents BI drug
Placebo
Placebo that represents BI drug
205.418.01020 Boehringer Ingelheim Investigational Site, Huntington Beach
205.418.01002 Boehringer Ingelheim Investigational Site, Mission Viejo
205.418.01014 Boehringer Ingelheim Investigational Site, San Diego
205.418.01011 Boehringer Ingelheim Investigational Site, Wheat Ridge
205.418.01004 Boehringer Ingelheim Investigational Site, Coeur d'Alene
205.418.01017 Boehringer Ingelheim Investigational Site, Normal
205.418.01008 Boehringer Ingelheim Investigational Site, South Bend
205.418.01012 Boehringer Ingelheim Investigational Site, Baltimore
205.418.01013 Boehringer Ingelheim Investigational Site, North Dartmouth
205.418.01015 Boehringer Ingelheim Investigational Site, North Dartmouth
205.418.01009 Boehringer Ingelheim Investigational Site, Minneapolis
205.418.01006 Boehringer Ingelheim Investigational Site, Bellevue
205.418.01016 Boehringer Ingelheim Investigational Site, Boys Town
205.418.01003 Boehringer Ingelheim Investigational Site, Omaha
205.418.01021 Boehringer Ingelheim Investigational Site, Winston-Salem
205.418.01018 Boehringer Ingelheim Investigational Site, Oklahoma City
205.418.01005 Boehringer Ingelheim Investigational Site, Charleston
205.418.01010 Boehringer Ingelheim Investigational Site, Easely
205.418.01007 Boehringer Ingelheim Investigational Site, Dallas
205.418.01019 Boehringer Ingelheim Investigational Site, Seattle
205.418.01001 Boehringer Ingelheim Investigational Site, Tacoma
205.418.55002 Boehringer Ingelheim Investigational Site, Juiz de Fora
205.418.55001 Boehringer Ingelheim Investigational Site, Porto Alegre
205.418.55004 Boehringer Ingelheim Investigational Site, Porto Alegre
205.418.55005 Boehringer Ingelheim Investigational Site, Porto Alegre
205.418.55003 Boehringer Ingelheim Investigational Site, Rio de Janeiro - RJ
205.418.86001 Boehringer Ingelheim Investigational Site, Beijing
205.418.86005 Boehringer Ingelheim Investigational Site, Beijing
205.418.86007 Boehringer Ingelheim Investigational Site, Beijing
205.418.86012 Boehringer Ingelheim Investigational Site, Beijing
205.418.86014 Boehringer Ingelheim Investigational Site, Changsha
205.418.86011 Boehringer Ingelheim Investigational Site, Chengdu
205.418.86015 Boehringer Ingelheim Investigational Site, Chengdu
205.418.86003 Boehringer Ingelheim Investigational Site, Chongqing
205.418.86010 Boehringer Ingelheim Investigational Site, Guangzhou
205.418.86013 Boehringer Ingelheim Investigational Site, Kunming
205.418.86008 Boehringer Ingelheim Investigational Site, Qingdao
205.418.86002 Boehringer Ingelheim Investigational Site, Shanghai
205.418.86004 Boehringer Ingelheim Investigational Site, Shenyang
205.418.86009 Boehringer Ingelheim Investigational Site, Shenyang
205.418.86006 Boehringer Ingelheim Investigational Site, Xi'an
205.418.50203 Boehringer Ingelheim Investigational Site, Guatelama City
205.418.50204 Boehringer Ingelheim Investigational Site, Guatelmala City
205.418.50205 Boehringer Ingelheim Investigational Site, Guatelmala City
205.418.50201 Boehringer Ingelheim Investigational Site, Guatemala City
205.418.50202 Boehringer Ingelheim Investigational Site, Guatemala City
205.418.91008 Boehringer Ingelheim Investigational Site, Banglore
205.418.91005 Boehringer Ingelheim Investigational Site, Chennai
205.418.91004 Boehringer Ingelheim Investigational Site, Coimbatore
205.418.91006 Boehringer Ingelheim Investigational Site, Coimbatore
205.418.91003 Boehringer Ingelheim Investigational Site, Hyderabad
205.418.91009 Boehringer Ingelheim Investigational Site, Jaipur
205.418.91002 Boehringer Ingelheim Investigational Site, Nagpur
205.418.91007 Boehringer Ingelheim Investigational Site, Pune
205.418.91010 Boehringer Ingelheim Investigational Site, Pune
205.418.81018 Boehringer Ingelheim Investigational Site, Adachi-ku, Tokyo
205.418.81030 Boehringer Ingelheim Investigational Site, Ako, Hyogo
205.418.81001 Boehringer Ingelheim Investigational Site, Chiyoda-ku, Tokyo
205.418.81005 Boehringer Ingelheim Investigational Site, Chuo-ku, Tokyo
205.418.81025 Boehringer Ingelheim Investigational Site, Chuo-ku, Tokyo
205.418.81015 Boehringer Ingelheim Investigational Site, Fujioka, Gunma
205.418.81023 Boehringer Ingelheim Investigational Site, Himeji, Hyogo
205.418.81007 Boehringer Ingelheim Investigational Site, Hitachi, Ibaraki
205.418.81009 Boehringer Ingelheim Investigational Site, Iwamizawa, Hokkaido
205.418.81028 Boehringer Ingelheim Investigational Site, Kanazawa, Ishikawa
205.418.81011 Boehringer Ingelheim Investigational Site, Kitakami, Iwate
205.418.81012 Boehringer Ingelheim Investigational Site, Kitakami, Iwate
205.418.81031 Boehringer Ingelheim Investigational Site, Koga, Ibaraki
205.418.81016 Boehringer Ingelheim Investigational Site, Koganei, Tokyo
205.418.81006 Boehringer Ingelheim Investigational Site, Komaki, Aichi
205.418.81002 Boehringer Ingelheim Investigational Site, Kunitachi, Tokyo
205.418.81004 Boehringer Ingelheim Investigational Site, Mito, Ibaraki
205.418.81032 Boehringer Ingelheim Investigational Site, Osaka, Osaka
205.418.81019 Boehringer Ingelheim Investigational Site, Ota-ku, Tokyo
205.418.81008 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido
205.418.81013 Boehringer Ingelheim Investigational Site, Sendai, Miyagi
205.418.81014 Boehringer Ingelheim Investigational Site, Sendai, Miyagi
205.418.81026 Boehringer Ingelheim Investigational Site, Setagaya-ku, Tokyo
205.418.81024 Boehringer Ingelheim Investigational Site, Takasaki, Gunma
205.418.81010 Boehringer Ingelheim Investigational Site, Tomakomai, Hokkaido
205.418.81003 Boehringer Ingelheim Investigational Site, Toshima-ku, Tokyo
205.418.81017 Boehringer Ingelheim Investigational Site, Toshima-ku, Tokyo
205.418.81022 Boehringer Ingelheim Investigational Site, Yao, Osaka
205.418.81020 Boehringer Ingelheim Investigational Site, Yokohama, Kanagawa
205.418.81021 Boehringer Ingelheim Investigational Site, Yokohama, Kanagawa
205.418.37004 Boehringer Ingelheim Investigational Site, Daugavpils
205.418.37008 Boehringer Ingelheim Investigational Site, Preiļi
205.418.37001 Boehringer Ingelheim Investigational Site, Riga
205.418.37002 Boehringer Ingelheim Investigational Site, Riga
205.418.37005 Boehringer Ingelheim Investigational Site, Riga
205.418.37006 Boehringer Ingelheim Investigational Site, Riga
205.418.37007 Boehringer Ingelheim Investigational Site, Riga
205.418.37009 Boehringer Ingelheim Investigational Site, Riga
205.418.37003 Boehringer Ingelheim Investigational Site, Ventspils
205.418.52002 Boehringer Ingelheim Investigational Site, Monterrey
205.418.52003 Boehringer Ingelheim Investigational Site, Zapopan
205.418.52001 Boehringer Ingelheim Investigational Site, Zona Río
205.418.51003 Boehringer Ingelheim Investigational Site, Callao
205.418.51001 Boehringer Ingelheim Investigational Site, Lima
205.418.51002 Boehringer Ingelheim Investigational Site, Lima
205.418.48006 Boehringer Ingelheim Investigational Site, Krakow
205.418.48001 Boehringer Ingelheim Investigational Site, Lodz
205.418.48005 Boehringer Ingelheim Investigational Site, Lodz
205.418.48002 Boehringer Ingelheim Investigational Site, Ostrow Wielkopolska
205.418.48004 Boehringer Ingelheim Investigational Site, Poznan
205.418.48003 Boehringer Ingelheim Investigational Site, Tczew
205.418.07007 Boehringer Ingelheim Investigational Site, Gatchina (Leningradskaya Oblast)
205.418.07004 Boehringer Ingelheim Investigational Site, Moscow
205.418.07005 Boehringer Ingelheim Investigational Site, Moscow
205.418.07006 Boehringer Ingelheim Investigational Site, Moscow
205.418.07008 Boehringer Ingelheim Investigational Site, Moscow
205.418.07001 Boehringer Ingelheim Investigational Site, Saint Petersburg
205.418.07002 Boehringer Ingelheim Investigational Site, Saint Petersburg
205.418.07003 Boehringer Ingelheim Investigational Site, Saint Petersburg
Lead Sponsor
Collaborators (1)
Pfizer
INDUSTRY
Boehringer Ingelheim
INDUSTRY